Zobrazeno 1 - 10
of 325
pro vyhledávání: '"Kazumasa Fujitani"'
Autor:
Atsushi Takeno, Masaaki Motoori, Kentaro Kishi, Takeshi Omori, Motohiro Hirao, Toru Masuzawa, Kazumasa Fujitani, Kazuyoshi Yamamato, Yukinori Kurokawa, Yuichiro Doki
Publikováno v:
Annals of Gastroenterological Surgery, Vol 8, Iss 3, Pp 431-442 (2024)
Abstract Background Conversion surgery (CS) is a highly anticipated strategy for stage IV advanced gastric cancer (AGC) with a good response to chemotherapy. However, prognostic factors limiting R0 resection remain unclear. In this multi‐institutio
Externí odkaz:
https://doaj.org/article/c059f0eccef74181a6b59eebdeb5ca7d
Autor:
Shu Aoyama, Yasuhiro Miyazaki, Masaaki Motoori, Masashi Hirota, Takefumi Itami, Sayaka Matsumoto, Masataka Hirano, Michihiro Aomatsu, Takasumi Goto, Mutsunori Kitahara, Yuki Ozato, Yujiro Nishizawa, Hisateru Komatsu, Akira Inoue, Yoshinori Kagawa, Akira Tomokuni, Kazuhiro Iwase, Hiroyuki Nishi, Kazumasa Fujitani
Publikováno v:
Surgical Case Reports, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Background Cardiac tamponade is a rare postoperative complication of esophageal cancer surgery, which leads to rapid hemodynamic changes and can be fatal if not treated properly and promptly. Herein, we report a case of cardiac tamponade aft
Externí odkaz:
https://doaj.org/article/46d843c9aa924e2e82d71928ffc0f971
Autor:
Masanori Terashima, Kazumasa Fujitani, Han‐Kwang Yang, Junki Mizusawa, Toshimasa Tsujinaka, Kenichi Nakamura, Hiroshi Katayama, Hyuk‐Joon Lee, Jun Ho Lee, Ji‐Yeong An, Akinori Takagane, Young‐Kyu Park, Seung Ho Choi, Kyo Young Song, Seiji Ito, Do Joong Park, Sung‐Ho Jin, Narikazu Boku, Takaki Yoshikawa, Mitsuru Sasako, REGATTA study investigators
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 5, Pp 741-749 (2023)
Abstract Background REGATTA trial failed to demonstrate the survival benefit of reduction gastrectomy in patients with advanced gastric cancer with a single non‐curable factor. However, a significant interaction was found between the treatment effe
Externí odkaz:
https://doaj.org/article/041974f2f89a4e099fb691e730289385
Autor:
Shunji Endo, Tetsuji Terazawa, Masahiro Goto, Ryo Tanaka, Takeshi Kato, Kazumasa Fujitani, Hisato Kawakami, Daisuke Sakai, Yukinori Kurokawa, Toshimasa Tsujinaka, Toshio Shimokawa, Taroh Satoh
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Large type 3 and type 4 gastric cancers have extremely poor prognoses. To address this, neoadjuvant chemotherapy may be a promising approach. The phase III JCOG0501 study, conducted to confirm the superiority of neoadjuvant S-1 pl
Externí odkaz:
https://doaj.org/article/64021a2d99e14bdca8abdc549a131c7c
Autor:
Hiroshi Imamura, Jin Matsuyama, Kazuhiro Nishikawa, Shunji Endo, Tomono Kawase, Yutaka Kimura, Junichi Fukui, Junji Kawada, Yukinori Kurokawa, Kazumasa Fujitani, Daisuke Sakai, Hisato Kawakami, Toshimasa Tsujinaka, Toshio Shimokawa, Yoshihiro Matsubara, Taroh Satoh, Hiroshi Furukawa, for the Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
Publikováno v:
Annals of Gastroenterological Surgery, Vol 5, Iss 6, Pp 776-784 (2021)
Abstract Aim Post‐surgical weight loss influences chemotherapy compliance and may be a risk factor for survival. Intake of an oral elemental nutritional supplement (OENS) can reduce weight loss after gastric cancer (GC) surgery. We assessed whether
Externí odkaz:
https://doaj.org/article/06d6b96a7dfb490eb264d804da24abd6
Autor:
Shu Aoyama, Masaaki Motoori, Yasuhiro Miyazaki, Tomoki Sugimoto, Yujiro Nishizawa, Hisateru Komatsu, Akira Inoue, Yoshinori Kagawa, Akira Tomokuni, Kazuhiro Iwase, Kazumasa Fujitani
Publikováno v:
Surgical Case Reports, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Background There are only few reported cases of remnant gastric cancer with concomitant afferent loop syndrome. Emergency surgery is the standard treatment strategy for this disease. However, some afferent loop syndrome cases, especially tho
Externí odkaz:
https://doaj.org/article/dd7b446bf723471ea33ec28e97df2efd
Autor:
Keijiro Sugimura, Makoto Yamasaki, Takushi Yasuda, Masahiko Yano, Motohiro Hirao, Kazumasa Fujitani, Yutaka Kimura, Hiroshi Miyata, Masaaki Motoori, Atsushi Takeno, Osamu Shiraishi, Tomoki Makino, Takayuki Kii, Koji Tanaka, Taro Satoh, Masaki Mori, Yuichiro Doki
Publikováno v:
Annals of Gastroenterological Surgery, Vol 5, Iss 1, Pp 75-82 (2021)
Abstract Aim The aim is to report the long‐term outcomes of preoperative cisplatin and fluorouracil plus docetaxel (DCF) vs Adriamycin (ACF) for resectable esophageal squamous cell carcinoma (ESCC). Previously, this trial showed that DCF is associa
Externí odkaz:
https://doaj.org/article/66bed07f867546eeb9fcf40f3ad6b2bd
Autor:
Tsutomu Hayashi, Takaki Yoshikawa, Kentaro Sakamaki, Kazuhiro Nishikawa, Kazumasa Fujitani, Kazuaki Tanabe, Kazunari Misawa, Takanori Matsui, Akira Miki, Hiroshi Nemoto, Tetsu Fukunaga, Yutaka Kimura, Jun Hihara
Publikováno v:
Annals of Gastroenterological Surgery, Vol 4, Iss 5, Pp 540-548 (2020)
Abstract Aim Neoadjuvant chemotherapy (NAC) is promising to improve the survival of resectable gastric cancer. However, suitable regimen and treatment duration for NAC have not yet been established. Methods We conducted a randomized phase II trial to
Externí odkaz:
https://doaj.org/article/f9e2aa86ef2344ac9777405e4e4ee24b
Autor:
Masaaki Motoori, Koji Tanaka, Keijiro Sugimura, Hiroshi Miyata, Takuro Saito, Yasuhiro Miyazaki, Kazumasa Fujitani, Yukiko Kado, Takashi Asahara, Masahiko Yano
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background The intestinal epithelial barrier allows absorption of dietary nutrients and prevents passage of pathogens and toxins into the body. Severe insults have a negative impact on the intestinal environment, which may decrease intestina
Externí odkaz:
https://doaj.org/article/3877243a0bef403093198f811503621e
Autor:
Hisato Kawakami, Kazuhiro Nishikawa, Toshio Shimokawa, Kazumasa Fujitani, Shigeyuki Tamura, Shunji Endo, Michiya Kobayashi, Junji Kawada, Yukinori Kurokawa, Akira Tsuburaya, Takaki Yoshikawa, Junichi Sakamoto, Taroh Satoh, on behalf of the HERBIS-2, HERBIS-4A and XParTS II Study Investigators
Publikováno v:
Cancers, Vol 14, Iss 22, p 5673 (2022)
It has been suggested that the therapeutic efficacy of S-1 + cisplatin (SP) and capecitabine + cisplatin (XP) may differ depending on the histology of the tumor, but no clear evidence exists. Individual participant data were obtained from three rando
Externí odkaz:
https://doaj.org/article/0b9f34706ae14e0fa9408bc2b102a357